Literature DB >> 6421398

Disodium etidronate in hypercalcaemia due to immobilisation.

E Hägg, M Eklund, O Tørring.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421398      PMCID: PMC1444330          DOI: 10.1136/bmj.288.6417.607-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Effect of the diphosphonate EHDP on bone mineral metabolism during prolonged bed rest.

Authors:  D R Lockwood; J M Vogel; V S Schneider; S B Hulley
Journal:  J Clin Endocrinol Metab       Date:  1975-09       Impact factor: 5.958

2.  Quantitative histological data on disuse osteoporosis: comparison with biological data.

Authors:  P Minaire; P Neunier; C Edouard; J Bernard; P Courpron; J Bourret
Journal:  Calcif Tissue Res       Date:  1974

3.  Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.

Authors:  H Fleisch; R G Russell; M D Francis
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

4.  Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients.

Authors:  P Minaire; E Berard; P J Meunier; C Edouard; G Goedert; G Pilonchery
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

  4 in total
  2 in total

1.  Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.

Authors:  H D McIntyre; D P Cameron; S M Urquhart; W E Davies
Journal:  Postgrad Med J       Date:  1989-04       Impact factor: 2.401

2.  Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient.

Authors:  N Varache; M Audran; P Clochon; A Lortholary; G Bouachour; P Alquier; M F Basle
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.